Multimodal CT-Based Risk Stratification for Postoperative Local Recurrence in NSCLC: A Multicenter Study
1 other identifier
observational
2,000
1 country
1
Brief Summary
This multicenter retrospective study is designed to develop and validate a CT-based multimodal risk stratification approach for postoperative local recurrence after curative-intent resection of non-small cell lung cancer (NSCLC). The approach integrates clinicopathologic variables, intratumoral and peritumoral radiomics, tumor-based 2.5D deep learning features, whole-lung deep learning features, and operative text features to capture complementary information related to tumor phenotype, pulmonary background, and surgical findings. Predictive performance and clinical utility will be evaluated in internal and external validation cohorts using the concordance index, time-dependent area under the receiver operating characteristic curve, decision curve analysis, and risk reclassification analyses. The objective of this study is to assess whether multimodal CT-based risk stratification may improve postoperative risk assessment and support individualized surveillance and management strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 14, 2026
CompletedFirst Posted
Study publicly available on registry
April 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedApril 27, 2026
April 1, 2026
3.1 years
April 14, 2026
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative local recurrence
From the date of surgery to first documented local recurrence, up to 3 years
Study Arms (2)
local recurrence after surgery
The primary endpoint was postoperative local recurrence, defined as recurrence within the ipsilateral hemithorax, including the bronchial stump or parenchymal margin, ipsilateral hilar or mediastinal lymph nodes, and pleural or chest wall seeding. Local recurrence was primarily determined by serial imaging assessment, with PET/CT and pathology used when necessary. To distinguish recurrence from a new primary lung cancer, lesion location, imaging features, histology, and timing were considered comprehensively.
non-local recurrence
stable or distant metastasis or death during follow-up
Eligibility Criteria
Patients with pathologically confirmed non-small cell lung cancer (NSCLC) who underwent curative-intent surgical resection and had preoperative contrast-enhanced chest CT available were retrospectively identified from participating centers. Eligible patients had complete clinicopathological, imaging, and follow-up data for assessment of postoperative local recurrence.
You may qualify if:
- Pathologically confirmed non-small cell lung cancer (NSCLC)
- Preoperative contrast-enhanced chest CT performed within 2 weeks before surgery
- Underwent routine postoperative follow-up
You may not qualify if:
- Small cell lung cancer or metastatic tumors
- Incomplete resection (R1/R2)
- No preoperative contrast-enhanced CT performed within 2 weeks before surgery
- History of other malignancies
- Inadequate follow-up or follow-up duration of 3 months or less
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Guangming Lulead
Study Sites (1)
Jinling Hospital
Nanjing, Jiangsu, 210002, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 14, 2026
First Posted
April 27, 2026
Study Start
January 1, 2023
Primary Completion
February 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
April 27, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL